235 related articles for article (PubMed ID: 27095645)
1. De Novo Malignancies After Transplantation: Risk and Surveillance Strategies.
Doycheva I; Amer S; Watt KD
Med Clin North Am; 2016 May; 100(3):551-67. PubMed ID: 27095645
[TBL] [Abstract][Full Text] [Related]
2. De novo malignancies after kidney and liver transplantations: experience on 582 consecutive cases.
Baccarani U; Adani GL; Montanaro D; Risaliti A; Lorenzin D; Avellini C; Tulissi P; Groppuzzo M; Currò G; Luvisetto F; Beltrami A; Bresadola V; Viale PL; Bresadola F
Transplant Proc; 2006 May; 38(4):1135-7. PubMed ID: 16757287
[TBL] [Abstract][Full Text] [Related]
3. De novo malignancies after liver transplantation: a major cause of late death.
Fung JJ; Jain A; Kwak EJ; Kusne S; Dvorchik I; Eghtesad B
Liver Transpl; 2001 Nov; 7(11 Suppl 1):S109-18. PubMed ID: 11689783
[TBL] [Abstract][Full Text] [Related]
4. De Novo neoplasia after liver transplantation: an analysis of risk factors and influence on survival.
Herrero JI; Lorenzo M; Quiroga J; Sangro B; Pardo F; Rotellar F; Alvarez-Cienfuegos J; Prieto J
Liver Transpl; 2005 Jan; 11(1):89-97. PubMed ID: 15690541
[TBL] [Abstract][Full Text] [Related]
5. Malignancy after Solid Organ Transplantation: Comprehensive Imaging Review.
Katabathina VS; Menias CO; Tammisetti VS; Lubner MG; Kielar A; Shaaban A; Mansour J; Surabhi VR; Hara AK
Radiographics; 2016; 36(5):1390-407. PubMed ID: 27618321
[TBL] [Abstract][Full Text] [Related]
6. De novo malignancies following liver transplantation: impact and recommendations.
Herrero JI
Liver Transpl; 2009 Nov; 15 Suppl 2():S90-4. PubMed ID: 19877025
[TBL] [Abstract][Full Text] [Related]
7. [Development of primary malignancies after liver and kidney transplantation and the treatment approach].
Bechstein WO; Dette K; Golling M; Wullstein Ch
Kongressbd Dtsch Ges Chir Kongr; 2002; 119():398-404. PubMed ID: 12704897
[TBL] [Abstract][Full Text] [Related]
8. Posttransplant malignancies in liver transplant recipients.
Akdur A; Kırnap M; Yıldırım S; Altundağ Ö; Moray G; Haberal M
Exp Clin Transplant; 2014 Mar; 12 Suppl 1():162-5. PubMed ID: 24635818
[TBL] [Abstract][Full Text] [Related]
9. National survey of de novo malignancy after solid organ transplantation in Japan.
Miyazaki T; Sato S; Kondo T; Kusaka M; Gotoh M; Saiki Y; Ono M; Kokudo N; Enosawa S; Satoh S; Soeda E; Furukawa H; Kobayashi E; Nagayasu T
Surg Today; 2018 Jun; 48(6):618-624. PubMed ID: 29380136
[TBL] [Abstract][Full Text] [Related]
10. De novo malignancy in heart transplant recipients: A single center experience in Japan.
Kimura Y; Yanase M; Mochizuki H; Iwasaki K; Toda K; Matsuda S; Takenaka H; Kumai Y; Kuroda K; Nakajima S; Watanabe T; Ikura MM; Wada K; Matsumoto Y; Seguchi O; Fukushima S; Fujita T; Kobayashi J; Fukushima N
J Cardiol; 2019 Mar; 73(3):255-261. PubMed ID: 30587457
[TBL] [Abstract][Full Text] [Related]
11. Burden of de novo malignancy in the liver transplant recipient.
Chandok N; Watt KD
Liver Transpl; 2012 Nov; 18(11):1277-89. PubMed ID: 22887956
[TBL] [Abstract][Full Text] [Related]
12. Incidence and long-term risk of de novo malignancies after liver transplantation with implications for prevention and detection.
Schrem H; Kurok M; Kaltenborn A; Vogel A; Walter U; Zachau L; Manns MP; Klempnauer J; Kleine M
Liver Transpl; 2013 Nov; 19(11):1252-61. PubMed ID: 24106037
[TBL] [Abstract][Full Text] [Related]
13. [Malignant neoplasias in renal transplantation recipients].
Gómez-Roel X; León-Rodríguez E
Rev Invest Clin; 2005; 57(2):225-9. PubMed ID: 16524062
[TBL] [Abstract][Full Text] [Related]
14. Complications of Immunosuppressive Therapy in Solid Organ Transplantation.
Katabathina V; Menias CO; Pickhardt P; Lubner M; Prasad SR
Radiol Clin North Am; 2016 Mar; 54(2):303-19. PubMed ID: 26896226
[TBL] [Abstract][Full Text] [Related]
15. Infectious Complications and Vaccinations in the Posttransplant Population.
Greendyke WG; Pereira MR
Med Clin North Am; 2016 May; 100(3):587-98. PubMed ID: 27095647
[TBL] [Abstract][Full Text] [Related]
16. Temporal Trends of De Novo Malignancy Development After Heart Transplantation.
Youn JC; Stehlik J; Wilk AR; Cherikh W; Kim IC; Park GH; Lund LH; Eisen HJ; Kim DY; Lee SK; Choi SW; Han S; Ryu KH; Kang SM; Kobashigawa JA
J Am Coll Cardiol; 2018 Jan; 71(1):40-49. PubMed ID: 29301626
[TBL] [Abstract][Full Text] [Related]
17. Impact of cyclosporine versus tacrolimus on the incidence of de novo malignancy following liver transplantation: a single center experience with 609 patients.
Wimmer CD; Angele MK; Schwarz B; Pratschke S; Rentsch M; Khandoga A; Guba M; Jauch KW; Bruns C; Graeb C
Transpl Int; 2013 Oct; 26(10):999-1006. PubMed ID: 23952102
[TBL] [Abstract][Full Text] [Related]
18. Management of de novo malignancies after liver transplantation.
Pillai AA
Transplant Rev (Orlando); 2015 Jan; 29(1):38-41. PubMed ID: 25510578
[TBL] [Abstract][Full Text] [Related]
19. De novo malignancy after liver transplant.
Sanaei AK; Aliakbarian M; Kazemi K; Nikeghbalian S; Shamsaeefar A; Mehdi SH; Bahreini A; Dehghani SM; Geramizadeh B; Malekhosseini SA
Exp Clin Transplant; 2015 Apr; 13(2):163-6. PubMed ID: 24844266
[TBL] [Abstract][Full Text] [Related]
20. De novo malignancy post-liver transplantation: a single center, population controlled study.
Chatrath H; Berman K; Vuppalanchi R; Slaven J; Kwo P; Tector AJ; Chalasani N; Ghabril M
Clin Transplant; 2013; 27(4):582-90. PubMed ID: 23808800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
